Synthekine

• NCT05665062

  Phase 1, Active, not recruiting, 36 people, 27 Dec 2022

• NCT05098132

  Phase 1/2, Recruiting, 364 people, 28 Oct 2021

• Targeting immune cells in the aged brain reveals that engineered cytokine IL-10 enhances neurogenesis and improves cognition

  Founder, 30 Jan 2026

Sources: pubmed.ncbi.nlm.nih.gov